Author

Shirel Lavi

Hebrew University of JerusalemORCID 0000-0002-2116-0332Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Abdelrahaman KarmiiD· 1 shared Anees KhatibiD· 1 shared Arata HayashiiD· 1 shared Areej Abu RmailehiD· 1 shared Balakrishnan SolaimuthuiD· 1 shared Itai MizrahiiD· 1 shared Michal Lichtenstein· 1 shared Ora Schueler‐FurmaniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdelrahaman KarmiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Dihydropyrimidines sustain aggressive cancer states by stabilizing DPYSL2

Arata Hayashi, Sarah Knapp, Abdelrahaman Karmi, Vaibhav Gupta, Itai Mizrahi, Shirel Lavi, Sinai Shammah, Yael Sitton, Ravit Glukhman, Balakrishnan Solaimuthu, Sayanika Banerjee, Areej Abu Rmaileh, Anees Khatib, Michal Lichtenstein, Ora Schueler‐Furman, , Yoav David Shaul

This study identifies dihydropyrimidines (DHPs) as signaling metabolites that sustain aggressive cancer states by stabilizing DPYSL2, linking metabolic activity to oncogenic signaling.

bioRxiv · Jun 18, 2026 · PreprintCancer Biology